Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

DiaSorin S.p.A.. (8/3/17). "Press Relase: DiaSorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017". Saluggia.

Organisations Organisation DiaSorin S.p.A. (FTSE Italia Mid Cap: DIA)
  Group DiaSorin (Group)
  Organisation 2 Siemens Healthcare GmbH (Siemens Healthineers)
  Group Siemens (Group)
Products Product Liaison analyzer
  Product 2 immunoassay (diagnostics, antibody-antigen-test)
Index term Index term DiaSorin–Qiagen: in vitro diagnostics, 201706– collab to adopt select Qiagen assays for use on Liaison platform
Persons Person Fava, Riccardo (DiaSorin 201607 IR + Corporate Communications Director)
  Person 2 Di Terlizzi, Ines (DiaSorin 201607 Investor Relations)
     


   
Record changed: 2017-08-10

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

More documents for DiaSorin (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnering Open 600x60px




» top